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Wnt growth factors are fundamental regulators of cell
fate, but how the Wnt signal is translated into biolog-
ical responses is incompletely understood. Here, we
report that TAZ, a biologically potent transcriptional
coactivator, serves as a downstream element of
the Wnt/b-catenin cascade. This function of TAZ is
independent from its well-established role as medi-
ator of Hippo signaling. In the absence of Wnt
activity, the components of the b-catenin destruction
complex—APC, Axin, and GSK3—are also required
to keep TAZ at low levels. TAZ degradation depends
on phosphorylated b-catenin that bridges TAZ to its
ubiquitin ligase b-TrCP. Upon Wnt signaling, escape
of b-catenin from the destruction complex impairs
TAZ degradation and leads to concomitant accumu-
lation of b-catenin and TAZ. At the genome-wide
level, a substantial portion of Wnt transcriptional
responses is mediated by TAZ. TAZ activation is a
general feature of Wnt signaling and is functionally
relevant to mediate Wnt biological effects.
INTRODUCTION
The Wnt signaling pathway has prominent and widespread roles
in development, tissue homeostasis, and cancer (MacDonald
et al., 2009). For example, Wnts coordinate proliferation and
differentiation during organ growth and serve as extrinsic factors
to regulate stem cells for tissue maintenance and regeneration
(Clevers, 2006; Moon et al., 2004; Niehrs and Acebron, 2012).
Aberrant activation of the Wnt cascade is a major theme in
cancer biology, leading to stem cell expansion and disturbed
tissue architecture. Thismay be caused bymutations of pathway
components or by autocrine signaling due to constitutive Wnt
production by tumor cells (Clevers, 2006).
A key step in this pathway is the regulation of cytosolic b-cat-
enin levels (MacDonald et al., 2009). In the absence of Wnt, a
multiprotein complex phosphorylates b-catenin and constantlyCtargets it for degradation. Key elements of this ‘‘destruction’’
complex are scaffold proteins, such as adenomatous polyposis
coli (APC) and Axin, and the b-catenin phosphorylating kinases
glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1)
(MacDonald et al., 2009). GSK3 phosphorylation of b-catenin is
critical for recognition by the F box protein b-TrCP and its asso-
ciated E3 ubiquitin ligase complex (Liu et al., 2002). Wnt signal-
ing inhibits b-catenin phosphorylation through sequestration of
GSK3 into multivesicular compartments and other mechanisms.
This causes b-catenin to escape from b-TrCP recognition, lead-
ing to its accumulation and formation of a nuclear complex with
the DNA-binding transcription factors TCF/Lef (Li et al., 2012;
Niehrs and Acebron, 2012; Taelman et al., 2010).
Wnt/TCF/b-catenin target genes account for important as-
pects of Wnt biology, an example being upregulation of c-myc
or cyclin-D1 in some tumors. Yet, it is also increasingly evident
that the highly temporal- and cell-specific expression of the
knownWnt/TCF/b-catenin targets can hardly capture the perva-
siveness and complexity of Wnt/b-catenin biology (Barolo, 2006;
Niehrs and Acebron, 2012). This raises the possibility that other
factors, in addition to b-catenin/TCF, may contribute to Wnt-
induced biological responses.
Independently of Wnt signaling, the transcriptional coactiva-
tors TAZ and YAP have recently emerged at the centerpiece of
poorly understood mechanisms that control tissue growth and
organ size (Pan, 2010). TAZ and YAP promote cell proliferation
and inhibit differentiation, particularly in stem cells and organ-
specific progenitors, and therefore, their activity must be
finely tuned in order to avoid loss of tissue regeneration and, at
the other extreme, overgrowth and emergence of tumors (Ra-
mos and Camargo, 2012). Furthermore, TAZ has been recently
proposed to endow self-renewal capacity to cancer stem cells
(Bhat et al., 2011; Cordenonsi et al., 2011).
TAZ and YAP are well known for their regulation by the Hippo
pathway; the activation of two kinases, MST1/2 (homolog of
Drosophila Hippo) and LATS1/2, leads to LATS-dependent
phosphorylation of TAZ and YAP, limiting their stability, nuclear
localization, and transcriptional activity (Pan, 2010). Recent find-
ings have emphasized the roles of cell polarity or cell-cell adhe-
sion as upstream regulators of the Hippo kinases (Cordenonsi
et al., 2011; Varelas et al., 2010b). Moreover, TAZ and YAP canell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc. 1443
Figure 1. Wnt Signaling Promotes TAZ Stabilization and Activation
(A) HEK293 cells were transfected with 8xGTIIC-Lux and either with control (siCo, lanes 1–3) or TAZ siRNAs (siTAZ, lane 4). After transfection, cells were exposed
to control- (Co) or Wnt3A-conditioned medium. Where indicated, XAV939 (1 mM, lane 3) was added. Top: luciferase assay of the indicated samples. Data are
normalized to lane 1 and are presented as mean +SD. Bottom: representative western blots for TAZ, YAP, b-catenin, and GAPDH (loading control) in the same
extracts used for the luciferase assay. See also Figure S1B for the validation of Wnt activity in conditioned media and of XAV939 efficacy on a b-catenin/TCF-
luciferase reporter.
(B) Wnt-induced transcriptional activation of 8xGTIIC-Lux (as in [A]) is independent of b-catenin.
(C) Top: luciferase assay on 8xGTIIC-Lux reporter recording TAZ-dependent transcriptional activity in HEK293 cells transfected with control (lanes 1 and 2),
GSK3 (lanes 3 and 4), APC (lanes 5 and 6), or Axin (lanes 7 and 8) siRNAs, either alone or with TAZ siRNA, as indicated. Data are normalized to lane 1 and are
presented as mean +SD. See Figures S1E, S1F, S1I, and S1K for siRNA validations. Bottom: western blot for TAZ in the same extracts used for the luciferase
assay.
(legend continued on next page)
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be regulated independently from the Hippo kinases by mechan-
ical and architectural cues, such as cytoskeletal tension and cell
shape (Dupont et al., 2011; Halder et al., 2012).
Interestingly, there are—at least superficially—clear elements
of overlap between b-catenin and TAZ or YAP; biochemically, all
are short-lived proteins in the cytoplasm, as they are degraded
by the same b-TrCP ubiquitin ligase complex (Liu et al., 2010;
MacDonald et al., 2009; Zhao et al., 2010). Biologically, they
appear to control overlapping processes in a number of epithelial
and nonepithelial contexts. Although this hints at some form of
joined regulation, the possibility that Wnt could signal through
TAZ or YAP stabilization has not been explored.
Here, we report the characterization of TAZ as a downstream
component of Wnt/b-catenin signaling cascade. We show that
Wnt induces TAZ protein stabilization and transcriptional activity
in multiple cell types and that this is essential for distinct biolog-
ical effects induced by Wnt signaling. We found that the
same destruction complex responsible for b-catenin degrada-
tion also restrains TAZ protein levels. Yet, TAZ does not require
direct phosphorylation by GSK3; rather, it is GSK3-phosphory-
lated b-catenin that serves as a scaffold for TAZ association
with b-TrCP/E3 ubiquitin-ligase complex. By inhibiting b-catenin
phosphorylation, Wnt promotes not only b-catenin stabilization




This study was initiated by the discovery that treatment of
HEK293 cells with Wnt3A triggered a remarkable increase of
TAZ protein levels (Figure 1A, bottom). Because TAZ mRNA
levels were not affected by Wnt3A (Figure S1A available online)
and because TAZ has been shown to be an unstable pro-
tein (Liu et al., 2010; data not shown), this suggested that
Wnt3A promoted TAZ protein stabilization. In contrast, Wnt3A
had no overt effect on YAP steady-state protein levels. Impor-
tantly, Wnt3A also triggered a robust induction of transfected
8xGTIIC-Lux (Figure 1A, compare lanes 1 and 2), a synthetic
luciferase sensor containing multimerized responsive elements
of TEAD, the main DNA-binding cofactor of TAZ or YAP (Dupont
et al., 2011). This induction was dependent on stabilization of
TAZ, as depletion of endogenous TAZ was sufficient to abolish
the effect of Wnt3A (Figure 1A, compare lanes 2 and 4), prompt-
ing us to investigate the link between Wnt and TAZ. Knockdown(D) Western blots for TAZ and YAP inMII human breast cancer cells transfected wi
GSK3 or APC siRNAs. TAZ mRNA levels remain unchanged (see Figures S1G, S
(E) qRT-PCR for TAZ target gene CTGF, normalized to GAPDH expression, in
mean +SD. See Figure S1L for an independent shRNA targeting TAZ.
(F) Confocal images of TAZ (left) in MII cells transfected as indicated in (D). Nucle
same fields.
(G) Pie chart of U133plus2 Affymetrix probesets upregulated in MII cells transfect
area of the graph represents the fraction of probesets whose upregulation by AP
(H) Upregulation of TAZ protein levels upon knockdown of GSK3, APC, or Axin i
(I) Western blot analysis of mouse ES cells, cultured in the absence or presence
(J–L) TAZ levels and expression of TAZ target genes in control and APC-deficient
deleted livers. (K and L) Average expression of TAZ target genes Cyr61 (K) and C
See also Figure S1.
Cof b-catenin had no effect on the induction of 8xGTIIC-Lux by
Wnt, ruling out that Wnt regulates TAZ stability indirectly, for
example, through b-catenin target genes (Figure 1B). We also
tested the possibility that Wnt might regulate TAZ by inhibiting
the Hippo kinase cascade. As shown in Figure S1C, treatment
with Wnt3A ligand could still induce TAZ in LATS1/2-depleted
cells, indicating that LATS activity is not crucial for TAZ regula-
tion by Wnt. We also expressed in HEK239 cells a phosphomu-
tant TAZ protein lacking all LATS phosphorylation sites (TAZ
4SA); as expected, TAZ 4SA is more stable than wild-type
TAZ, and yet it remains sensitive to Wnt regulation (Figure S1D).
Taken together, these data suggested that Wnt signaling stabi-
lizes and activates TAZ by mechanisms other than regulation
of the Hippo pathway.
Wnt ligands are transduced intracellularly through the inacti-
vation of the b-catenin destruction complex, which includes
GSK3, APC, and Axin (MacDonald et al., 2009). We sought to
determine whether Wnt regulates TAZ through the same path-
way. We thus reactivated the b-catenin destruction complex in
Wnt-treated cells by using XAV939, a small molecule that pro-
motes Axin stabilization (Huang et al., 2009). XAV939 inhibited
the effects of Wnt3A on TAZ transcriptional activity and stability
(Figure 1A, compare lanes 2 and 3). Conversely, depletion of
Axin, GSK3, or APC induced TAZ stabilization and activity (Fig-
ure 1C), phenocopying Wnt stimulation. As a control, depletion
of LATS was irrelevant for TAZ regulation by GSK3 or APC
(data not shown), again indicating that activation of TAZ by the
Wnt signaling cascade does not rely on Hippo pathway inhibi-
tion. Thus, Wnt signaling regulates TAZ in a way that depends
on the b-catenin destruction complex.
Next, we tested the validity of this conclusion in a different
cellular model system. In transformed mammary epithelial cells
(MCF10A-T1k or MII cells), knockdown of GSK3, APC, or Axin
caused robust TAZ stabilization (Figures 1D, S1F, S1H, and
S1J) and promoted TAZ-dependent upregulation of CTGF (Fig-
ures 1E and S1L), an established endogenous readout of TAZ
activity (Cordenonsi et al., 2011). This was paralleled by nuclear
accumulation of endogenous TAZ (Figure 1F).
Next, we wished to investigate to what extent Wnt gene re-
sponses are mediated by TAZ on the transcriptomic scale. For
this, we compared the Affymetrix gene expression profiles of
MII cells transfected with control small interfering RNA (siRNA),
APC siRNA, or the combination of APC and TAZ siRNAs. We
first identified a list of 739 probesets upregulated more than
two times after APC depletion, thus entailing Wnt-induced targetth control, GSK3, APC, or Axin siRNAs. See Figures S1F and S1H for alternative
1I, and S1K).
MII-shGFP or MII-shTAZ#3 transfected with the indicated siRNAs. Bars are
i are stained with Hoechst (right). See Figure S1M for b-catenin staining in the
ed with APC siRNA compared to control siRNA-transfected cells. Dark colored
C depletion is reverted by cotransfection of TAZ siRNA.
n HeLa cells, HaCaT cells, and human mesenchymal stem cells (hMSC).
of the GSK3 inhibitor CHIR99021 (CHIR, 3 mM) for 24 hr.
mouse livers (n = 3 for each genotype). (J) Upregulation of TAZ protein in APC-
TGF (L), evaluated by qRT-PCRs. Data are presented as mean +SD.
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genes. Strikingly, 54% of these probesets were upregulated in
a TAZ-dependent manner (Figure 1G); if we restricted our anal-
yses to genes upregulated more than five times by APC knock-
down, out of 132 probesets, 91 (70%) were TAZ dependent.
These results indicate that TAZ is a relevant mediator of Wnt-
induced transcriptional responses in this cellular context.
We also found that Wnt pathway activation, either by stimula-
tion with Wnt3A or by intracellular inhibition of the destruction
complex, led to TAZ stabilization and induction of TAZ-depen-
dent gene responses in a variety of cell types, such as in HeLa
cervical carcinoma cells, HaCaT immortalized keratinocytes,
primary human mesenchymal stem cells, mouse embryonic
stem (ES) cells, and P19 mouse embryonic carcinoma cells
(Figures 1H, 1I, and S1N). In sum, TAZ activation by Wnt is a
general phenomenon irrespective of cell transformation, epithe-
lial or mesenchymal status, and embryonic lineage.
Finally, to extend our finding to in vivo conditions, we crossed
mice bearing APC floxed alleles (APCfl/fl) with transgenic mice
carrying the inducible Ah-Cre recombinase, in which robust
Cre expression in liver, gut, and other organs can be induced
by the drug b-naphtophlavone (see Extended Experimental
Procedures). In liver extracts, genetic inactivation of APC trig-
gered, as expected, the induction of the b-catenin/TCF target
Cyclin-D1 (Figure S1O) and also triggered a strong upregulation
of TAZ protein levels and of the TAZ targetsCyr61 andCTGF, but
not of TAZ mRNA (Figures 1J–1L and S1P).
Taken together, the data indicate that Wnt activity is a general
inducer of TAZ stabilization and TAZ-dependent transcription,
that TAZ regulation accounts for a significant portion of Wnt-
regulated genes, and that TAZ levels are kept low by the same
set of core proteins—Axin, APC, and GSK3—that continually
keep b-catenin levels in check.
TAZ Mediates Wnt Biological Responses
Finding that the b-catenin destruction complex regulates TAZ
carries a corollary: in APC mutant cells, TAZ should be already
at the maximal level allowed by this regulation and thus should
be insensitive to GSK3 inactivation. To test this hypothesis, we
used the SW480 colorectal cancer (CRC) cell line, carrying a
homozygous nonsense mutation in APC (Faux et al., 2004).
Indeed, depletion of GSK3 had no effect on TAZ stability in
SW480 cells (Figure 2A, compare lanes 1 and 2). However, add-
ing back APC to SW480 cells not only dramatically downregu-
lated TAZ protein levels and the expression of TAZ target genes
(Figure 2A, compare lanes 1 and 3) but also restored sensitivity to
GSK3 inhibition (Figure 2A, compare lanes 3 and 4). Thus, aber-
rant Wnt signaling in CRC cells entails TAZ stabilization.
b-catenin is a key player downstream of oncogenic Wnt
signaling for the growth of CRC cells (van de Wetering et al.,
2002). Here, we asked whether TAZ might also have important
functions in this context. Knockdown of either TAZ or b-catenin
reduced the proliferation of parental SW480 cells to a similar
extent, with dual depletion of b-catenin and TAZ being required
for a complete growth arrest (Figure 2B, lanes 2–4). APC recon-
stitution led to a severe growth suppression (Figure 2B, compare
lanes 1 and 5), as previously reported (Faux et al., 2004); forced
expression of TAZ rescued proliferation of APC-reconstituted
SW480 cells (lane 6). Of note, manipulation of the levels of TAZ1446 Cell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc.(by gain or loss of function) does not influence b-catenin levels
(Figure S2B), suggesting that TAZ does not operate through
b-catenin stabilization. Furthermore, loss of TAZ does notmodify
the expression of Axin2 and Cyclin-D1, two of the most estab-
lished readouts of the TCF/b-catenin complex, ruling out that
TAZ is required for TCF-dependent transcription (Figure 2C).
Taken together, these data suggest that TAZ is essential and
instrumental for cell proliferation downstream of aberrant Wnt
signaling, cooperating with the well-established function of
b-catenin in this process.
Parental SW480 cells are highly transformed and able to grow
as clonal ‘‘spheroids’’ in Matrigel (Figure 2E). Consistently with
the role of Wnt signaling as promoter of clonogenic potential
(Niehrs and Acebron, 2012), we found that the status of APC
also contributes to the capacity of SW480 cells to grow under 3D
conditions. Indeed, APC-reconstituted SW480 cells formed a
much-reduced number of colonies than parental SW480 cells
(Figures 2D, 2E, and 2H). Remarkably, TAZ depletion in parental
SW480 cells impaired spheroid formation, whereas knockdown
of b-catenin did not (Figures 2E–2H). In sum, APC deficiency
empowers 2D cell growth in a manner that is dependent both
on b-catenin and on TAZ, aswell as clonogenic properties, which
are prevalently dependent on TAZ stabilization.
We then wished to assess, beyond any specific functional
assay, what is the relative contribution of b-catenin and TAZ
to the global Wnt gene response in CRC cells. For this, we
compared the Affymetrix gene expression profiles of paren-
tal, TAZ-depleted, b-catenin-depleted, and APC-reconstituted
SW480 cells. Importantly, we found that b-catenin and TAZ
accounted for one-third and one-sixth of the 3,000 probesets
modulated by APC reconstitution, respectively (p values <
1032). This indicates that TAZ targets represent a substantial
fraction of gene expression driven by oncogenic APC.
TAZ Is Required for Wnt-Dependent Differentiation of
Mesenchymal Stem Cells
We next addressed the role of TAZ as a downstreammediator of
Wnt signals during Wnt-dependent differentiation of mesen-
chymal stem cells (MSC). Wnt signaling is indeed critical for
bone formation in mammals, and, at least in part, this is due to
the requirement of Wnts to promote an osteogenic lineage in
mesenchymal progenitors (Leucht et al., 2008). To address the
role of TAZ in this process, we used ST-2 murine bone marrow
stromal cells and primary human MSC.
In mouse ST-2 cells, treatment with recombinant Wnt3A
caused a robust increase in alkaline phosphatase (ALP), amarker
of bone differentiation (Figure 3A, top, compare lanes 1 and 3).
Notably, this occurred with a parallel rise of b-catenin and TAZ
protein levels (Figure 3A, bottom). Strikingly, TAZ depletion had
no effect on b-catenin levels but was sufficient to impair ALP
induction by Wnt3A (lane 4), indicating that TAZ is an essential
mediator of bone differentiation induced by Wnt in this cellular
context.
Human MSC can be induced to differentiate into the osteo-
blast lineage by switching their culturing condition from regular
growth medium to osteogenic differentiation medium. Addition
of recombinant Dkk-1, an extracellular Wnt antagonist, severely
impaired bone differentiation (Figures 3B–3D), a finding in line
Figure 2. Role of TAZ in Growth and Clonogenic Potential of APC Mutant Colon Cancer Cells
(A)Western blots for TAZ, CTGF, andGSK3 in parental (APCmutant) and APC-reconstituted SW480 cells, transfectedwith control (lanes 1 and 3) or GSK3 siRNAs
(lanes 2 and 4).Wild-type APC expression effectively reduced b-catenin levels and activity (Figure S2A and see [C] below), indicating the effective reconstitution of
the destruction complex. Other TAZ target genes, such as Ankyrin-D1 and Cyr61, were equally downregulated by APC reconstitution (data not shown).
(B) Growth assay in SW480 cells transfected with control (siCo), TAZ (siTAZ), b-catenin (sibcat), or both TAZ and b-catenin (sibcat siTAZ) siRNAs. In lane 6, APC-
reconstituted SW480 cells were stably transduced with TAZ-expressing lentiviral vector. Bars display the number of SW480 cells counted 1 day after seeding
(light blue bars) or after 4 days (dark blue bars). Data are shown as mean +SD. See Figure S2B for TAZ and b-catenin expression in these samples. See Figures
S2C–S2F for growth curves of parental SW480 cells transfected with independent TAZ or b-catenin siRNAs.
(C) Bars are expression values of Axin2 and Cyclin-D1 mRNAs in parental or APC-reconstituted SW480 cells transfected with the indicated siRNAs. Data are
presented as mean +SD.
(D–G) Representative pictures of Matrigel-embedded spheres formed by SW480+APC (D) or SW480 (E–G) cells transfected with the indicated siRNAs.
(H) Bars represent the number of spheres formed by the indicated cells. Data are shown as mean +SD.
See also Figure S2.with the notion that autocrine Wnt ligands are essential for this
process. Interestingly, we found that TAZ protein levels rose
upon switching cells in osteogenicmedium, but this was blocked
by concomitant addition of Dkk-1 (Figure 3F, compare lanes 1, 2,
and 3). If, as previously implicated in ST-2 cells, TAZ induction is
instrumental for bone differentiation downstream of Wnt, then
raising TAZ levels should bypass the extracellular block posed
by Dkk-1. For this experiment, we sustained TAZ expression
by transducing MSC with a TAZ lentiviral vector (Figure 3F,
lane 4). Crucially, reconstitution of TAZ restored bone dif-
ferentiation of Dkk1-treated hMSC (Figure 3E; see quantifica-
tions in Figure S3B). Interestingly, the TAZ targets CTGF and
Cyr61 were induced during osteogenic differentiation of MSC
in a manner that was TAZ dependent, opposed by Dkk-1, and
rescued by exogenous TAZ (Figures 3A and 3F). Taken together,
the data reveal that Wnt promotes MSC differentiation into oste-
oblasts through TAZ stabilization.
Contrary to bone differentiation, adoption of an adipogenic
fate by MSC is inhibited by Wnt (Ross et al., 2000), and loss ofCAxin, GSK3, or APC severely blunted adipocytic differentiation
(Figures 3G, 3H, and S3C–S3G). This inhibition was mediated
by upregulation of endogenous TAZ as double depletion of
Axin, and TAZ restored adipocyte differentiation (Figures 3I
and 3J). Similar results were obtained by double knockdowns
of TAZ and GSK3 or TAZ and APC (data not shown). These
epistatic relationships reinforce the notion that regulation of
TAZ by the Wnt pathway is functionally relevant for MSC
differentiation.
Role of GSK3 in TAZ Degradation
Next, we sought to determine by which mechanism Wnt sig-
naling promotes TAZ activity. The results described so far sug-
gested that stabilization of b-catenin and TAZ are both down-
stream of Wnt signaling because both proteins are degraded
by the same destruction complex. The view that TAZ follows
the same steps of b-catenin on its route to degradation is sug-
gested by the fact that b-TrCP is required for both TAZ and
b-catenin degradation (MacDonald et al., 2009; Liu et al., 2010)ell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc. 1447
Figure 3. Role of TAZ in Wnt-Controlled Mesenchymal Stem Cell Differentiation
(A) Wnt3A promotes bone differentiation in a TAZ-dependent manner in ST-2 cells. ST-2 cells were transfected with control (lanes 1 and 3) or TAZ (lanes 2 and 4)
siRNAs. Where indicated, cells were exposed to recombinant Wnt3A (lanes 3 and 4). Top: alkaline phosphatase (ALP) activity. Data are presented as mean +SD.
Bottom: western blots for TAZ, Cyr61, and b-catenin in the corresponding extracts. GAPDH serves as loading control. Wnt3A does not affect TAZmRNA levels
(Figure S3A).
(B–F) TAZ rescues bone differentiation in Dkk1-treated hMSC. hMSC, transducedwith lentiviral vectors encoding for control (empty vector) or TAZ, were cultured
either in growth medium (GM) or osteogenic differentiation medium (ODM); where indicated, Dkk-1 protein (500 ng/ml) was added to the ODM. (B–E) Repre-
sentative fields of hMSC stained for ALP. See Figure S3B for quantifications of ALP-positive areas. (F) Western blots for TAZ, Cyr61, CTGF, and b-catenin in the
samples described above. b-catenin was still inhibited by Dkk-1 in TAZ-transduced MSCs (lanes 3 and 4).
(G–J) hMSCwere transfected with control or Axin siRNAs, alone or with TAZ siRNA (siTAZ), and induced to differentiate in adipocytes. (G–I) Representative fields
of hMSC, stained with oil red to visualize lipid droplets. Nuclei are stained with Hoechst. (J) Quantification of oil-red-positive areas. Values are mean +SD.
See also Figure S3.and was further supported by the following evidence: (1) TAZ
protein levels increased after depletion of b-TrCP (Figures 4A
and S4A); (2) loss of b-TrCP also promoted potent upregulation
of TAZ transcriptional responses (Figure S4A); (3) similar to
b-TrCP depletion, interfering with Cullin1, an essential adaptor
of the b-TrCP E3 ubiquitin ligase complex, caused upregulation
of TAZ (Figure S4A).
The interaction of b-catenin with b-TrCP occurs upon phos-
phorylation by GSK3 (MacDonald et al., 2009). We then tested
whether GSK3 phosphorylation and b-TrCP recognition also
drive TAZ degradation. We first tested this hypothesis by
assaying whether the interaction of TAZ with b-TrCP required
GSK3. Indeed, endogenous b-TrCP failed to associate to TAZ
in coimmunoprecipitation assays from lysates of GSK3-depleted
MII cells (Figure 4B). Moreover, GSK3 kinase activity is essential1448 Cell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc.for TAZ degradation; knockdown of GSK3 stabilized TAZ in
MII cells (Figure 4C, lanes 1 versus 2 and 4 versus 5), and re-
constitution with wild-type GSK3 (Figure 4C, lane 3), but not
with kinase-dead GSK3 (Figure 4C, lane 6), rescued TAZ
levels and activity. Similar results were obtained in HEK293
cells (Figure S4B). These findings are in line with the effect of
CHIR99021, a small-molecule inhibitor of GSK3 enzymatic
activity, leading to TAZ stabilization in a variety of cell types (Fig-
ure 1I; data not shown).
GSK3 regulates the stability of b-catenin and other proteins
through phosphorylation of a DSGXXS motif, called ‘‘phospho-
degron’’ (Taelman et al., 2010; Kim et al., 2009; Xu et al.,
2009). Phosphorylation of the two serines in the phosphodegron
potentially tags a given protein for b-TrCP recognition, ubiquiti-
nation, and proteosomal degradation. Regulation of TAZ stability
Figure 4. The Kinase Activity of GSK3 Is Essential for TAZ Degradation by b-TrCP
(A) Endogenous TAZ is degraded by b-TrCP. b-TrCP depletion leads to TAZ stabilization in MII cells, as revealed by western blot. GAPDH serves as loading
control.
(B) Endogenous TAZ binds to b-TrCP in a GSK3-dependent manner. Coimmunoprecipitation/western blot analysis of MII cell lysates shows that endogenous
b-TrCP is pulled down specifically by TAZ (lane 1 versus 2) only in the presence of GSK3 (lane 2 versus 3).
(C) GSK3 kinase activity is essential to dampen TAZ protein levels and function. MII cells were engineered to express doxycycline-inducible/siRNA-insensitive
human GSK3b, either wild-type (wt; lanes 1–3) or kinase-dead mutant (KD; lanes 4–6). After depletion of endogenous GSK3 by siRNA transfection (lanes 2, 3, 5,
and 6), cells were exposed to 0.5 mg/ml doxycycline to induce the expression of either wt GSK3b (lane 3) or KDGSK3b (lane 6). Lanes 1 and 4 are cells transfected
with control siRNA. Top: quantitative real-time PCRs forCTGF (mean +SD). Bottom: western blots for TAZ and GSK3. Lane 1 versus 2 and lane 4 versus 5: TAZ is
stabilized and activated (CTGF induction) upon GSK3 depletion; lane 3: reconstitution with wt GSK3b rescues the effect of GSK3 depletion; lane 6: reconstitution
with KD GSK3b has no effect.
(D) GSK3 regulates TAZ independently of its phosphodegron. Lanes 1 and 2: western blot for endogenous TAZ shows its stabilization upon GSK3 depletion.
Lanes 3–6:MII cells were transfectedwith TAZ siRNA (to avoid interference from regulations of endogenous TAZ) and reconstitutedwith siRNA-insensitivemouse
TAZ, either wt (lanes 3 and 4), or S58/62Amutant (lanes 5 and 6). Both wild-type and S58/62A TAZ are sensitive to GSK3 siRNA. See Figures S4D and S4E for TAZ
mRNA levels.
(E)Wnt activates TAZ independently of its GSK3-phosphodegron. HEK293 cells were transfectedwith the synthetic 8xGTIIC-Lux reporter. Lanes 1 and 2:Wnt3A-
conditioned medium activates the reporter. Lanes 3 and 4: knockdown of endogenous TAZ abolishes the effect of Wnt. Lanes 5–8: cells were transfected with
TAZ siRNA to avoid interference from regulations of endogenous TAZ and were reconstituted with either mouse wt TAZ (lanes 5 and 6) or TAZ S58/62A (lanes
7 and 8). The phosphodegron is irrelevant for TAZ activation by Wnt (lanes 6 and 8). Bars are mean +SD.
See also Figure S4.by GSK3 has been previously documented downstream of
PI3K/AKT signaling through phosphorylation of an N-terminal
phosphodegron motif, entailing S58 and S62 (Huang et al.,
2012) (see Figure S4C). This raised the possibility that, in analogy
to b-catenin, GSK3 might promote TAZ degradation by phos-
phorylating these two sites also in the context of the Wnt
cascade. If this were the case, mutation of those two residues
from serine to alanine should render TAZ resistant to GSK3-
mediated degradation. In stark contrast with this prediction,
both wild-type and S58/62A TAZ were similarly stabilized by
GSK3 knockdown (Figure 4D). Moreover, the activity of TAZ
S58/62A could still be induced by Wnt3A (Figure 4E). We
conclude that GSK3 keeps TAZ levels low irrespective of integ-
rity of the N-terminal TAZ phosphodegron.
Taken together, the results indicated that, although GSK3
kinase activity is essential for TAZ association to b-TrCP, a
mechanism entailing direct GSK3 phosphorylation of TAZ wasCunlikely. We thus considered that the effect of GSK3 on TAZ
stability was primarily indirect, that is, through modification of
an intermediary protein serving as adaptor for TAZ degradation.
And, in the context of Wnt signaling, the most likely culprit was
b-catenin itself, whose degradation is well known to require
direct GSK3 phosphorylation.
b-Catenin Promotes TAZ Degradation
By coimmunoprecipitation, we found that b-catenin and TAZ
form a complex at endogenous protein levels (Figures 5A and
S5A), prompting us to test whether b-catenin was required for
TAZ association to b-TrCP and TAZ degradation. Intriguingly,
depletion of b-catenin by siRNA revealed that b-catenin was
required for the endogenous association of TAZ to b-TrCP in
MII cells (Figure 5B). Furthermore, knockdown of b-catenin by
independent siRNAs caused a robust stabilization of TAZ pro-
tein, induction of TAZ transcriptional activity, and TAZ nuclearell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc. 1449
Figure 5. Role of b-Catenin for TAZ Degradation
(A and B) b-catenin associates with TAZ at endogenous protein levels (A) and is required for TAZ interaction with b-TrCP (B). Endogenous TAZ was immuno-
precipitated from lysates of MII cells transfected with control, b-catenin, or TAZ siRNAs by using anti-TAZ antibody, and coprecipitating proteins were detected
by western blot.
(C) Endogenous b-catenin is required for TAZ degradation. MII cells were transfected with control or b-catenin siRNAs. Top: quantitative real-time PCRs for TAZ
target CTGF. Bars are mean +SD, normalized to lane 1. Bottom: western blots for TAZ and b-catenin. GAPDH serves as loading control. TAZmRNA expression
wasn’t affected by b-catenin depletion (data not shown).
(D) Luciferase assay on 8xGTIIC reporter in HEK293 cells transfected with control or b-catenin siRNAs, with or without TAZ siRNA. Data are normalized to control
siRNA-transfected cells, and bars are mean +SD.
(E) Representative confocal images of TAZ (top) in MII cells transfected with control or b-catenin siRNAs. Nuclei are stained with Hoechst (bottom). See also
Figure S5B.
(F) The WW domain of TAZ is required for association to b-catenin and b-TrCP. TAZ was immunoprecipitated from lysates of MII cells stably expressing Flag-
tagged wild-type or DWW TAZ by using anti-Flag antibody, and co-precipitating proteins were detected by Western blot.
(G) Luciferase assay on 8xGTIIC reporter recording the transcriptional activity of wild-type or DWW TAZ transiently transfected in HEK293 cells in the absence
(Co) or presence (Wnt3A) of Wnt stimulation. Cells were transfected with TAZ siRNA to avoid interference from regulations of endogenous TAZ. Data are
normalized to lane 1 and are presented as mean +SD. Bottom: western blots for TAZ in the same extracts used for the luciferase assay.
See also Figure S5.accumulation (Figures 5C–5E and S5B). Of note, loss of b-cate-
nin was not accompanied by events known to regulate TAZ
through the Hippo pathway (Cordenonsi et al., 2011), that is,
downregulation of cadherin adherens junctions, epithelial-mes-
enchymal transition, disturbed apico-basal polarity, or changes
in the levels of active LATS (Figures S5C and S5D).
Our results thus suggested a model whereby b-catenin plays
a central role in TAZ inhibition by bridging TAZ to the b-TrCP
complex (Figure 6A, left). In this scenario, a TAZ mutant that
cannot interact with b-catenin should not bind b-TrCP, nor
should it be regulated by Wnt signaling. To validate this notion,
we carried out mapping studies by using recombinant GST-
TAZ deletion constructs and in-vitro-translated b-catenin. The1450 Cell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc.results revealed that the ‘‘WW’’ domain of TAZ was required
for association to b-catenin (Figure S5E). Once expressed in
human cells not experiencing Wnt signaling, TAZ deleted of the
WW domain (TAZDWW) was more stable and basally more
active than wild-type TAZ (Figures 5G and S5F), correlating
with the incapacity of TAZDWW to associate to endogenous
b-catenin and b-TrCP (Figure 5F). As predicted, TAZDWW could
not be further stabilized nor activated by Wnt signaling (Fig-
ure 5G). Critically, the hyperactive behavior of TAZDWW could
not be ascribed to an escape from the Hippo pathway, as
TAZDWW is still phosphorylated on the leading LATS target
S306 and can be further stabilized by LATS1/2 depletion (Figures
S5G and S5H). We conclude from these structure-function
experiments that, in Wnt-OFF cells, b-catenin bridges TAZ to
b-TrCP (Figure 6A, left). Activation of the Wnt pathway reduces
such association of b-catenin to b-TrCP and, consequently,
dampens TAZ degradation (Figure 6A, middle).
In the Wnt-OFF world, cytoplasmic b-catenin is recruited to
b-TrCP after being phosphorylated by GSK3, whose kinase
activity is also critical for TAZ degradation (Figure 4). Is the
GSK3-phosphorylated pool of b-catenin the ultimate mediator
of TAZ degradation? For this, we analyzed TAZ stability and
CTGF induction in two MII cell lines, which were depleted of
endogenous b-catenin and reconstituted at near-to-endoge-
nous levels with either wild-type b-catenin or a phosphomutant
b-catenin (Figure 6B). This mutant harbors N-terminal point
mutations (serine to alanine, S/A) that prevent GSK3 phosphor-
ylation and b-TrCP recognition (Liu et al., 2002). As above,
knockdown of b-catenin promoted TAZ stabilization in both MII
derivatives (Figure 6B, lanes 1 and 2 and lanes 4 and 5); adding
back wild-type b-catenin rescued TAZ degradation (Figure 6B,
lane 3). However, reconstitution with S/A phosphomutant b-cat-
enin had no effect (Figure 6B, lane 6), indicating that TAZ degra-
dation relies on b-catenin phosphorylation by GSK3. In these
experiments, changes in TAZ protein levels were consistently
paralleled by changes in its activity, as indicated by the expres-
sion of its target CTGF (Figure 6B).
Further support to the model proposed in Figure 6A was
provided by experiments in HepG2 hepatoma cells. These cells
carry two different b-catenin alleles: one encoding wild-type
b-catenin and the other encoding a constitutively active b-cate-
nin bearing a natural deletion in the N terminus encompassing
the GSK3 phosphorylation sites (Figure 6C). We designed
a siRNA oligonucleotide (#4) that specifically binds within the
deletion and, as such, only targets the wild-type and not the
mutated allele. By using this siRNA, we found that the sole
wild-type b-catenin is responsible for TAZ degradation (Fig-
ure 6D, compare lanes 1 and 5), as depletion of both isoforms
does not further increase TAZ stability (Figure 6D, compare lanes
1, 3, and 5). Conversely, b-catenin-dependent induction of one
of its transcriptional targets, Cyclin-D1, is almost exclusively
supported by the mutant allele (Figure S6C). Thus, the HepG2
model system allows uncoupling of the two functions of b-cate-
nin: nuclear/transcriptional activity, a function almost exclusively
mediated by the stabilized b-catenin, and TAZ degradation,
which requires a phosphorylatable b-catenin.
We then asked whether the role of b-catenin as TAZ inhibitor
is functionally relevant for TAZ activity. TAZ and Wnt have
been independently proposed as critical factors in sustaining
the self-renewal of normal and transformed mammary epithelial
cells, as assessed in mammosphere assay (Cordenonsi et al.,
2011; Scheel et al., 2011). For example, TAZ depletion impairs
formation of mammospheres in cell populations enriched of
prospective cancer stem cells, whereas gain of TAZ promotes
mammosphere potential in otherwise non-stem-cell populations
(Cordenonsi et al., 2011). In line with b-catenin depletion leading
to TAZ stabilization, knockdown of b-catenin in MII cells caused
an increase in mammosphere formation that was blunted upon
concomitant depletion of TAZ (Figure 6E).
We next sought to determine to what extent b-catenin serves
as endogenous TAZ inhibitor in cells lacking Wnt stimulation orConcogenic activation of the pathway. For this, we first monitored
by microarray profiling the global transcriptional effects of b-cat-
enin depletion in MII cells and then asked to what extent these
were dependent on TAZ upregulation. We found that b-catenin
depletion led to induction of about 350 probesets; a remarkable
74%of this list was TAZ dependent, as induction of these probe-
sets was reverted by concomitant loss of TAZ (Figure 6F). Inter-
estingly, >90% of the TAZ-dependent probesets upregulated by
b-catenin depletion were also upregulated by APC depletion in
a TAZ-dependent manner (Figure 1G) and, thus, represented
targets of the following pathway:
Wnt signaling C APC/Phospho-b-catenin C TAZ
The results collectively indicate that APC-regulated cytoplasmic
b-catenin, so far considered transcriptionally irrelevant and only
meant to be degraded, is in fact a potent repressor of the TAZ
transcriptional program.
g-Catenin Participates in TAZ Regulation
g-catenin is a homolog of b-catenin, and the two proteins are
thought to operate in an overlapping manner in several con-
texts: they have redundant functions in cell adhesion and share
Wnt-dependent regulation through phosphorylation by GSK3
and b-TrCP-mediated degradation (Xu et al., 2009). Importantly,
TAZ associates with g-catenin at endogenous protein levels
(Figure 6G), and, similarly to b-catenin, this interaction is depen-
dent on the integrity of the TAZ WW domain (Figure S6F). This
prompted us to test whether g-catenin also shares with b-cate-
nin the capacity to regulate TAZ. To examine this, we monitored
TAZ activity in HEK293 cells transfected with siRNAs against
b-catenin, g-catenin, or both. Depletion of g-catenin led to
TAZ stabilization (Figure 6H) and TAZ-dependent transcriptional
activity (Figure 6I, lane 5). Interestingly, concomitant depletion
of both b- and g-catenin resulted in even stronger transcrip-
tional activation (Figure 6I). This indicates that these factors
play independent and additive roles in TAZ inhibition.
Finally, we tested whether depletion of g-catenin is sufficient
to sustain the biological functions of TAZ even in the absence
of Wnt stimulation. For this, we chose to monitor osteogenic
differentiation of bone marrow cells that—as shown above (Fig-
ure 3)—is promoted by Wnt through TAZ stabilization. Indeed,
depletion of g-catenin in murine bone marrow stromal cells
induced a robust increase of TAZ protein and TAZ-dependent
activation of the osteogenic program (Figure 6J). This activity
closely resembles the effects of Wnt ligands and suggests that
b-catenin and its homolog g-catenin play a relevant role in the
control of TAZ stability and activity.
DISCUSSION
In this work, we have presented evidence indicating that TAZ is
downstream of Wnt signaling and is critical for some established
Wnt-dependent biological responses.
Inhibition of theb-catenin destruction complex is central toWnt
signaling; this results in b-catenin stabilization. In this classic
view, b-catenin is the last known element of the Wnt signaling
cascade. Here, we reveal the existence of a new downstreamell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc. 1451
Figure 6. TAZ Regulation by the Wnt/b-Catenin Pathway
(A) A model depicting the proposed mechanism for TAZ regulation by Wnt pathway and b-catenin. See Discussion.
(B) Phospho-b-catenin mediates TAZ degradation. MII cells were engineered to express doxycycline-inducible siRNA-insensitive b-catenin, either wt (lanes 1–3)
or phosphomutant (S/A, lanes 4–6). After depletion of endogenous b-catenin by siRNA (lanes 2, 3, 5, and 6), cells were treated with 0.5 mg/ml doxycycline to
induce the expression of wt (lane 3) or S/A b-catenin (lane 6). Lanes 1 and 4were cells transfectedwith control siRNA. Panels are western blots for TAZ, CTGF, and
b-catenin. Lane 1 versus 2 and lane 4 versus 5: TAZ is stabilized and activated upon b-catenin depletion; lane 3: reconstitution with wt b-catenin rescues TAZ
inhibition; lane 6: S/A b-catenin cannot revert the effect of b-catenin siRNA. Both wt and S/A b-catenin are equally able to localize to the plasma membrane (see
Figure S6A).
(C) Scheme of the two transcripts (and protein products) encoded by the wt (black) and exon3/exon4-deleted (del ex3-4, blue) b-catenin alleles of HepG2 cells.
The phosphodegron site on wild-type b-catenin, missing in the mutant protein, is in orange. The regions of b-cateninmRNA targeted by siRNAs are indicated in
red; as the sequence targeted by siRNA#4 is within the deletion, this siRNA only hits the wild-type transcripts, whereas siRNA#3 is used to deplete both isoforms.
(legend continued on next page)
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layer in this cascade, revealing a key role for b-catenin in
regulating the stability of another potent transcriptional coactiva-
tor, TAZ.
TAZ as a Downstream Mediator of Wnt Signaling
The results shed new light on the modalities by which the Wnt
pathway controls gene expression. Prior to this work, we could
have equated the Wnt signal only to the genes controlled by
b-catenin through its association to TCF/Lef. Here, we show
that formation of the b-catenin/TCF complex is not the sole
modality by which the Wnt/b-catenin pathway can regulate
gene expression, as we found that TAZ protein stabilization
and TAZ-mediated transcription are also a general feature of
the Wnt response in a variety of cellular model systems. It
is noteworthy that, when we challenged by gene expression
profiling the global relevance of TAZ downstream of Wnt sig-
naling, that is, in a manner that goes beyond by the use of
specific bioassays or genetic sensors, the regulation of a very
significant fraction of Wnt target genes turned out to be TAZ
dependent both in mammary epithelial cells and in colorectal
cancer cells.
We propose that Wnt signaling has thus two consequences:
to turn on the transcriptional functions of b-catenin, as so far
acknowledged, and to turn on the transcriptional functions of
TAZ. The specific relevance of these two aspects will likely
depend on the cellular context. In some cell types, or experi-
mental conditions, the effects of Wnt may primarily depend
on TCF-dependent transcription. However, we reason that the
most likely situation will be one in which both b-catenin- and
TAZ-dependent biological effects are occurring at the same
time in response to Wnt pathway activation. For example, in
colorectal cancer cells, the presence of oncogenic mutations
in APC potently stabilizes both b-catenin and TAZ, with both
factors sustaining cell proliferation. Still, even in this oncogenic
setup, we could highlight a specific role of TAZ in endowing
clonogenic potential to CRC cells, a function not shared by stabi-
lized b-catenin. Similarly, TAZ plays essential roles in the regula-
tion of mesenchymal stem cell differentiation, likely in concert
with, and complementary to, b-catenin.
Makita et al. (2008) reported that a minor fraction of TAZ
mutant mice develop to term, suggesting that TAZ may primarily(D) HepG2 cells were transfected with b-catenin siRNAs indicated in (C), with or wi
lane 1. Bottom: western blots for TAZ and b-catenin. Depletion of the sole wild-ty
stability and activity without affecting TAZ mRNA expression or the transcription
(E) Quantification of mammospheres formed by MII cells transfected with con
mean +SEM. See Figure S6D for independent b-catenin siRNAs.
(F) Pie chart of U133plus2 Affymetrix probesets upregulated in MII cells transfec
colored area of the graph represents the fraction of probesets whose upregulati
(G) Coimmunoprecipitation between endogenous TAZ and g-catenin in MII cell l
(H) Western blots for TAZ and g-catenin in extracts from HEK293 cells transfected
mediated phosphorylation of LATS (Figure S6G).
(I) Luciferase assay on 8xGTIIC reporter in HEK293 cells transfected with control, b
siRNA. Data are normalized to control siRNA-transfected cells, and bars are m
interfering sequences (Figure S6H; data not shown).
(J) Effects of g-catenin downregulation on TAZ expression and on osteoblastic d
and TAZ siRNAs as indicated. Left: ALP activity (mean +SEM). Right: western b
g-catenin siRNA (data not shown).
See also Figure S6.
Ccontribute to Wnt responses in adult tissues. It must be also
noticed, however, that the vast majority of TAZ mutants die in
utero with an as-yet-uncharacterized phenotype (Makita et al.,
2008); in fact, we have been unable to obtain any TAZ/
newborn in our colony (L.A. and S.P., unpublished data). This
leaves open the potential of an overlap between Wnt and TAZ
also in embryonic development, perhaps consistently with the
severe phenotype of TAZ-deficient zebrafish embryos (Hong
et al., 2005).
TAZ and its related protein YAP are functionally redundant
during embryonic development, with double knockouts failing
to form the blastocyst (Nishioka et al., 2009). In this work, we
have focused on TAZ because of its overt stabilization by Wnt
signaling and functional relevance in Wnt bioassays. A question
is whether YAP may be also controlled by Wnt through similar or
unrelated mechanisms; of note, a complex between b-catenin
and YAP has been previously reported (Imajo et al., 2012).
Although we failed to detect changes in YAP protein steady-
state levels upon Wnt signaling, YAP stability may be regulated
more finely or at the level of nuclear activity and nucleo-cyto-
plasmic localization. Dedicated studies are required to dissect
these possibilities.
A New Role for b-Catenin
Here, we propose a distinct perspective on Wnt signaling
whereby b-catenin plays active roles both in the presence and
absence of Wnt ligands (Figure 6A). In the absence of Wnt
signaling (i.e., Wnt OFF state), the pool of phospho-b-catenin
is an essential element for continuous TAZ degradation, as it
serves as critical scaffold for TAZ recognition by the b-TrCP E3
ubiquitin ligase. This configures an unexpected role for cyto-
plasmic b-catenin: besides being recruited to the destruction
complex for its own degradation, b-catenin works as yet another
intermediary of the Wnt cascade upstream of TAZ. Much evi-
dence supports this conclusion, including (1) TAZ and b-catenin
form a complex at endogenous protein levels in unstimulated
cells; (2) b-catenin phosphorylation is required for TAZ degrada-
tion; and (3) depletion of both GSK3 and b-catenin impairs TAZ/
b-TrCP interaction.
One possible interpretation of these results would be that
TAZ could only bind the phosphorylated form of b-catenin.thout TAZ siRNA. Top: qRT-PCRs forCTGF. Bars are mean +SD, normalized to
pe pool of b-catenin (with siRNA#4, lanes 5 and 6) is sufficient to promote TAZ
al activity of the mutant b-catenin pool (see Figures S6B and S6C).
trol or b-catenin siRNAs, with or without TAZ siRNA. Data are presented as
ted with b-catenin siRNA compared to control siRNA-transfected cells. Dark
on by b-catenin depletion is reverted by cotransfection of TAZ siRNA.
ysates.
with control or gcatenin siRNAs. Depletion of g-catenin didn’t reduce MST-
-catenin (sibcat), or g-catenin (sigcat) siRNAs as indicated, with or without TAZ
ean +SD. Similar results were obtained with different b-catenin or g-catenin
ifferentiation of ST-2 cells. ST-2 cells were transfected with control, g-catenin,
lots for TAZ and g-catenin. Similar results were obtained with an alternative
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However, TAZ and b-catenin proteins can associate in vitro,
arguing against a strict requirement of b-catenin phosphoryla-
tion. Another equally plausible interpretation is that, irrespec-
tively of b-catenin phosphorylation per se, TAZ may effectively
associate to b-catenin only after cytoplasmic b-catenin is
captured by the destruction complex, a scenario that is compat-
ible with other proteins of the destruction complex either rein-
forcing the b-catenin/TAZ interaction or escorting the b-cate-
nin/TAZ/b-TrCP recognition.
The relevance of b-catenin as endogenous inhibitor of TAZ
was validated at the genome-wide level in mammary epithelial
cells by microarray experiments. These analyses uncovered
that APC-regulated cytoplasmic b-catenin, per se transcrip-
tionally irrelevant, does nevertheless actively control gene ex-
pression, as it restrains the TAZ-dependent gene expression
program (Figure 6F). As proof of principle of the functional rele-
vance of this inhibition, we used an established TAZ biological
assay (mammosphere assay; Cordenonsi et al., 2011) and
confirmed that b-catenin depletion enhances TAZ activity in
mammary epithelial cells.
g-catenin represents yet another variation on this scenario;
this b-catenin-related protein is regulated by the Wnt/GSK3/
b-TrCP axis, but its relevance for TCF-dependent transcription
is still debated (Ben-Ze’ev, 1999). Nevertheless, here we show
that g-catenin is able to regulate TAZ-dependent transcriptional
responses by promoting TAZ instability in concert, or redun-
dantly, with b-catenin. From this ‘‘TAZ perspective,’’ g-catenin
may effectively be part of the Wnt response.
We propose that, in cells experiencing Wnt activity, b-catenin,
per se largely dissociated from b-TrCP, is incapable of carrying
out any adaptor function for TAZ and, as such, is irrelevant for
TAZ regulation (Figure 6A). In this view, it is the loss of the asso-
ciation of phospho-b-catenin to b-TrCP that causes TAZ stabili-
zation; we found that TAZ is indeed stabilized not only by Wnt
signaling but also by experimental removal of b-catenin (Fig-
ure 6A, middle and right). It also follows that removing b-catenin
from cells where the fraction of phospho-b-catenin is negli-
gible—such as Wnt-treated cells or cells carrying oncogenic
APC—is inconsequential for an already stabilized TAZ protein.
In fact, b-catenin knockdown cannot further increase TAZ levels
in APC-deficient SW480 colon cancer cells (Figure S2B, lane 3)
nor TAZ-dependent transcription in Wnt-stimulated HEK293
cells (Figure 1B, lane 3).
The functions of the two pools of b-catenin could be visualized
at the endogenous level and within the same cellular context by
using HepG2 cells, which contain both wild-type and a nonphos-
phorylatable mutant b-catenin. In line with our model, only wild-
type b-catenin is relevant to oppose TAZ; mutant-b-catenin is
unable to bring TAZ to degradation, whereas it mediates the
b-catenin/TCF transcriptional responses.
TAZ Stability at the Crossroad between Wnt and Hippo
Signaling
Cell-cell adhesion and polarity cues activate the Hippo/LATS
kinases, leading to TAZ phosphorylation and sequestration in
the cytoplasm (Cordenonsi et al., 2011; Pan, 2010). More
recently, a largely LATS-independent modality to regulate TAZ
stability and activity has been also shown to occur as conse-1454 Cell 151, 1443–1456, December 21, 2012 ª2012 Elsevier Inc.quence of changes in cell shape and cytoskeletal reorganization
induced by mechanical cues, such as rigidity of the extracellular
matrix (Dupont et al., 2011). Here, we further expanded the land-
scape of TAZ regulation by showing that TAZ is controlled by
a major family of secreted growth factors in a manner largely
independent fromHippo signaling. This network accommodates
self-regulating feedback loops; TAZ was demonstrated to nega-
tively regulate the Wnt pathway by inhibiting Dishevelled, a posi-
tive Wnt regulator (Varelas et al., 2010a). This may provide a
ceiling to the levels of TAZ activation by Wnts and a mechanism
to turn off TAZ-dependent responses.
One point worth discussing is that TAZ is phosphorylated by
LATS and CK1 to generate a C-terminal phosphodegron that
has been shown to be relevant for TAZ stability and to promote
direct association to b-TrCP, at least under conditions of protein
overexpression (Liu et al., 2010). This is apparently at odds with
the present findings indicating that, at endogenous protein
levels, TAZ and b-TrCP associate indirectly through a b-catenin
bridge. In fact, these two scenarios are perfectly compatible, as
these represent formally independent modalities of regulating
TAZ stability by the Hippo and Wnt cascades, respectively.
Indeed, here we show that LATS inhibition or mutation of the
LATS or CK1 phosphorylation sites are irrelevant for TAZ regula-
tion by Wnt (Figures S1C and S1D; data not shown); conversely,
a TAZ mutant unable to bind b-catenin is insensitive to Wnt but
remains under LATS1/2 control. Taken together, these findings
open very intriguing possibilities for TAZ as a hub integrating
different physiological inputs.
Finally, having established TAZ as Wnt effector opens up
many therapeutic possibilities. Targeting TAZ could curb aber-
rant Wnt signaling in a variety of cancers and other disorders.
Conversely, targeting the Wnt pathway by restoring the integ-
rity of the destruction complex would effectively inhibit, at




Luciferase reporters (50 ng/cm2) were transfected together with CMV-b-gal
(75 ng/cm2) to normalize for transfection efficiency with CPRG (Roche) colori-
metic assay. For luciferase assays in siRNA-depleted cells, cells were first
transfected with the indicated siRNAs and, after 24 hr, were transfected with
plasmid DNA. Where indicated, cells were exposed to control- or Wnt3A-
conditioned medium for 24 hr before harvesting. Each sample was transfected
in duplicate, and each experiment was repeated at least three times indepen-
dently. siRNA sequences are listed in Table S1.
MSC Differentiation Assays
For bone differentiation of ST-2 mouse cells, cells were cultured in the pres-
ence of 100 mg/ml ascorbic acid (Sigma) and 5 mM b-glicerophosphate
(Sigma), alone or in combination with 100 ng/ml recombinant Wnt3A (Pepro-
tech) for 72 hr. Cells were then harvested in 0.5% Triton X-100, and alkaline
phosphatase (ALP) activity was assessed by measuring spectroscopycally
at 405 nm the hydrolysis of p-nitrophenyl phosphate (Sigma) to p-nitrophenol
(expressed as nmol/min/mg protein) after a 10 min incubation at room temper-
ature. Data were normalized to the total protein content, determined by
Bradford. For bone differentiation of hMSC, cells were switched from growth
medium (GM) to osteogenic differentiation medium (ODM) 24 hr after seeding;
medium was then renewed every 2 days for a total of 10 days of differen-
tiation. MSC were then fixed and assayed by ALP staining kit (Sigma 85L2).
Adipogenic differentiation of hMSC and quantifications of ALP-positive or
oil-red-positive areas were carried out as in Dupont et al. (2011).
Western Blot, Immunoprecipitation, and qPCR
MII cells were grown for 2 days at high density. Extracts and total RNA were
prepared and analyzed as in Cordenonsi et al. (2011). Immunoprecipitations
were carried out as in Cordenonsi et al. (2011) by using the anti-TAZ mono-
clonal antibody from BD Biosciences, the anti-b-catenin monoclonal antibody
(E-5) from Santa Cruz, or the anti-Flag-tag monoclonal antibody (M2) from
Sigma.
See also Extended Experimental Procedures.
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